...
Authors
Clear selection
...
Beeinflusst die Umstellung von Risedronat oder Alendronat Originalprodukten auf Generika die Compliance (Persistenz)?

Osteologie-Kongress der Deutschen Gesellschaft für Osteologie, 05. - 07.03.2009, Frankfurt, Germany

Conflicts of interests: The DAPI received financial support for this study from Procter and Gamble Pharmaceuticals; Moehrke W. employee Procter and Gamble Pharmaceuticals; Hadji P. consultant for Procter and Gamble Pharmaceuticals.